Archives
-
0.4% Trypan Blue Solution: Practical Cell Viability Guide
2026-08-15
0.4% Trypan Blue Solution, SKU K1183, supports rapid cell viability measurement, live/dead cell discrimination, and cell counting by staining dead or membrane-damaged cells blue. It is intended for research workflows such as cell culture and cytotoxicity assays, not for diagnostic, clinical, or medical use.
-
From Proximity Labels to Low-Background Biology
2026-08-14
A translational guide to selecting Streptavidin-HyperFluor™ 647 for low-background biotin detection while understanding when click-compatible, biotin-free proximity labeling is the better strategic choice.
-
Berberine Hydrochloride in AMPK Research
2026-08-14
Build reproducible metabolic, lipid, and mitochondrial assays with Berberine hydrochloride, from DMSO stock preparation to LDLR and AMPK pathway validation. A recent cardiotoxicity study provides a useful assay blueprint while also clarifying where evidence for berberine itself remains preliminary.
-
CTP Solution for Reproducible mRNA Workflows
2026-08-13
CTP Solution (100 mM) provides a defined Cytidine-5'-triphosphate input for IVT, RNA amplification, and mRNA–LNP research. This guide connects practical nucleotide handling with the localized p21 mRNA delivery strategy reported in bladder cancer while distinguishing product-supported specifications from workflow recommendations.
-
ABT-199 (GDC-0199): Selective Bcl-2 Inhibitor
2026-08-13
This dossier-guided article explains how to use ABT-199, also known as Venetoclax, in BCL-2-focused apoptosis assays and hematologic malignancy models. It is appropriate for controlled research workflows, but it should not be treated as a clinical dosing guide or as an inhibitor of MCL-1, BCL-XL, or BCL-w.
-
Honokiol Workflows for In Vitro Cancer Response
2026-08-12
Honokiol supports mechanism-aware cancer assays that distinguish growth suppression from genuine cell killing. This guide pairs NF-κB, oxidative-stress, and antiangiogenic readouts with practical formulation, dosing, normalization, and troubleshooting strategies.
-
AP-2α Reverses TMZ Resistance in Recurrent GBM
2026-08-12
The reference study identifies AP-2α as a transcriptional suppressor of MGMT in recurrent glioma and shows that loss of this regulatory axis contributes to temozolomide resistance. By combining promoter assays, DNA-damage measurements, retinoic acid treatment, and intracranial models, the work connects MGMT regulation to a potentially actionable strategy for restoring TMZ sensitivity.
-
Citrate Molarity Shapes mRNA-LNP Function
2026-08-11
This study shows that citrate buffer molarity can alter mRNA-LNP biological performance even when conventional measurements such as average particle size, polydispersity, and encapsulation efficiency appear similar. The findings support evaluating particle sub-populations, morphology, cellular uptake, and expression alongside standard critical quality attributes during formulation development.
-
Mouse Tissue Lysis Kit: Direct Genotyping Guide
2026-08-11
The Mouse Tissue Lysis Kit (K1038) simplifies preparation of mouse tissue lysates for direct PCR-based genotyping by avoiding separate DNA extraction or purification. It is intended for molecular biology research and assay development, not for diagnostic, clinical, or medical use.
-
Moxidectin–Polyene Synergy in Oral Candidiasis
2026-08-10
A 2024 study found that moxidectin potentiates amphotericin B and Nystatin against Candida albicans by increasing ergosterol biosynthesis, thereby strengthening polyene binding to fungal membranes. Transcriptomic, genetic, biochemical, and mouse-model data support ergosterol remodeling as the central mechanism and suggest a strategy for using lower polyene exposure in oral candidiasis research.
-
Firefly Luciferase mRNA: Workflow Guide
2026-08-09
Build more reproducible mRNA delivery, translation, viability, and imaging assays with a Cap1-capped, 5-moUTP-modified luciferase transcript. This guide connects practical RNA handling and transfection controls with bench-scale LNP platform selection and troubleshooting.
-
Urolithin A in Mitochondrial-Fibrosis Research
2026-08-08
Use Urolithin A to test whether mitochondrial quality control reshapes hepatic stellate cell metabolism, while keeping the glutamine–GDH–SIRT4 pathway as a mechanistic comparator. This workflow separates established antifibrotic evidence from hypothesis-generating applications of a mitophagy-focused metabolite.
-
NHS-Biotin for Smarter Protein Assay Design
2026-08-07
NHS-Biotin enables controlled labeling of antibodies, proteins, and intracellular amines through stable amide-bond formation. This article explains how its chemistry should—and should not—be combined with emerging nanobody multimerization strategies.
-
Mouse Neutrophil Cell Isolation Kit: Advanced Immunotherapy
2026-08-07
Unlock high-purity neutrophil isolation with the APExBIO Mouse Neutrophil Cell Isolation Kit (Negative Selection), designed for functional, activation-free research. Streamline your workflow with rapid, column-free magnetic separation—empowering next-gen immunotherapy and tumor microenvironment studies.
-
Ciprofloxacin Workflows: Advanced Research Use of a Fluoroqu
2026-08-06
Ciprofloxacin stands out as a research-grade fluoroquinolone antibiotic, enabling high-impact workflows from antimicrobial resistance modeling to nanotheranostic innovation. This article delivers actionable protocols, troubleshooting strategies, and fresh insights from the latest reference study—guiding you to reliable and reproducible data in bacterial and cancer research contexts.